# Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/upregulation-of-pd-l1-by-eml4-alk-fusion-protein-mediates-the-immune-escape-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shaodong Hong,Nan Chen,Wenfeng Fang,Jianhua Zhan,Qing Liu,Shiyang Kang,Xiaobo He,Lin Liu,Ting Zhou,Jiaxing Huang,Ying Chen,Tao Qin,Yaxiong Zhang,Yuxiang Ma,Yunpeng Yang,Yuanyuan Zhao,Yan Huang,Li Zhang |
| Citations | 136 |
| DOI | 10.1080/2162402x.2015.1094598 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1094598?needAccess=true&role=button |
| OpenAlex ID | https://openalex.org/W2259317756 |
| PMID | 27141355 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Yuanyuan Zhao](https://scholariq.org/researchers/yuanyuan-zhao/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.